Connect your AI

The RMR Group RMR Restricted Cash Equivalents in Other Assets

Restricted Cash Equivalents in Other Assets at other companies

Agilon HealthAGL

$71.58M+4,156%

Achieve Life SciencesACHV

$52K+33.3%

Amylyx Pharmaceuticals, Inc.AMLX

$986K-32.0%

Vor BiopharmaVOR

$168K-93.0%

Liberty Broadband CorporationLBRDK

$57M-57.8%

AshlandASH

$276M+1.5%

Other financials

Income statement

Revenue$145.6M-12.6%

Operating income$7.0M-6.9%

Net income$1.0M-72.2%

EPS (diluted)$0.05-76.2%

Balance sheet

Cash & equivalents$80.1M-41.6%

Total debt$20.9M-18.9%

Total equity$227.6M-2.9%

Total assets$684.6M+5.4%

Cash flow

Operating cash flow$48.8M+277%

CapEx$2.7M+311%

Free cash flow$46.1M+275%

Valuation

Market cap$355.71M+29.3%

Enterprise value$296.46M+81.2%

P/E17.1×+3.5×

P/S0.6×+0.2×

Profitability

Operating margin9.4%+4.0pp

Net margin3.2%+0.7pp

FCF margin14.4%+4.2pp

Returns & leverage

Return on equity9%+0.5pp

Debt / equity0.1×0.0×

Current ratio1.7×-0.8×

Where this comes from

Reported directly by The RMR Group in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashEquivalents.

The official record: The RMR Group’s 10-K, filed November 12, 2025, on SEC EDGAR. View the filing →

Ask your AI about The RMR Group's restricted cash equivalents in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is The RMR Group's restricted cash equivalents in other assets?: The RMR Group (RMR) reported restricted cash equivalents in other assets of $1.8M in Q3 2025.